Key facts
- This page summarizes Azmi Nabulsi's Form 4 filing for Phathom Pharmaceuticals, Inc. (PHAT).
- 1 reported transaction and 0 derivative rows are listed below.
- Accepted by SEC: 31 May 2024, 18:34.
Azmi Nabulsi - 31 May 2024 Form 4 Insider Report for Phathom Pharmaceuticals, Inc. (PHAT)
- Reporting relationship
- Chief Operating Officer
- Issuer ticker
- PHAT
- Reported as of
- 31 May 2024
- Net transaction value
- $0
- SEC form
- 4
- Accepted by SEC
- 31 May 2024, 18:34:53 UTC
- Prior SEC filing
- 22 Jan 2024
- Next SEC filing
- 17 Jul 2024
- Source filing
- View source filing
- Reporting owner signature
- /s/ Molly Henderson, Attorney-in-Fact for Azmi Nabulsi
Source evidence
Original filing metadata and source links for verification.
5 source fields
Reporting owner
1 detail
Key filing fact
Azmi Nabulsi filed Form 4 for Phathom Pharmaceuticals, Inc. (PHAT) on 31 May 2024.
Change
- Previous filing in this sequence was filed on 22 Jan 2024.
- Current net transaction value: $0.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
PHAT
transaction
Common Stoock
Award
- Transaction value
- $0
- Shares
- +7,500
- Change %
- +3.1%
- Price
- $0.000000
- Shares after
- 249,567
- Date
- 31 May 2024
- Ownership
- Direct
- Footnotes
- F1
PHAT
holding
Common Stock
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- 3,579
- Date
- 31 May 2024
- Ownership
- By 401(k)
PHAT
holding
Common Stock
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- 785,700
- Date
- 31 May 2024
- Ownership
- By Trust
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 1 footnote
Footnote F1
Represents restricted stock units ("RSUs") granted on May 31, 2024. One third (1/3) of the total number of RSUs granted vest on each of the first three anniversaries of December 18, 2023, the vesting commencement date, subject to the Reporting Person's continued service on the applicable vesting date. Each RSU represents a contingent right to receive one share of common stock of the Issuer.